A Mendelian randomisation study provides initial evidence that sex hormone binding globulin (SHBG) levels alter type 2 diabetes risk
Perry Jrb., David Melzer, Marcello Maggio, Damián Hernández, Andrew B. Singleton, Luigi Ferrucci, Nicholette D. Palmer, Allyson J. Bennett, Aimo Ruokonen, Vijay Panicker, Paul M Ridker, Andrew T. Hattersley, Margaret M. McCarthy, Timothy M. Frayling (2008). A Mendelian randomisation study provides initial evidence that sex hormone binding globulin (SHBG) levels alter type 2 diabetes risk. , 51
